Event: “Landing Your Company in the Boston Life Sciences Ecosystem” 

By Greg Mannix, VP, EMEA Business Development, LSN

The Soft-Landing program, held at the Cambridge Innovation Center (CIC), offered an insightful look into how international companies can effectively establish a foothold in the U.S. life science market, with a focus on the Boston-Cambridge area—one of the world’s most significant hubs for life sciences. The event attracted over 100 registrants interested in commencing operations in the region. The CIC, which also presented during the event, provided an ideal backdrop as a key hub for regional innovation and collaboration.

The day started with introductions by Life Science Nation (LSN), providing an overview of the investor landscape and the crucial role it plays in supporting life sciences in the region. This was followed by MassBio’s presentation, emphasizing their efforts to fuel the ecosystem in Massachusetts, and an introduction to the Massachusetts Life Science Center highlighting their programs and significant resources that support incoming companies.

Legal considerations and steps for establishing a business in the U.S., including the Delaware flip, were covered by McDermott Will & Emery, providing valuable information for companies looking to set up in the United States. The CIC spoke about where to set up operations in Boston, and Abi Lab discussed opportunities beyond Kendall Square, offering a comprehensive view of the life science ecosystem in the Greater Boston area.

A networking lunch provided participants with the opportunity to connect with other attendees, forming connections and gaining additional insight.

In the afternoon, participants attended a CEO roundtable discussion that examined the pros and cons of being based in Greater Boston, followed by presentations from PwC on launching great science with great partnerships and Cambridge Scientific on securing lab space in the area. Polsinelli covered key patent and FDA considerations for navigating regulatory landscapes in the U.S., while Banc of California provided insights into banking and financial matters critical to establishing a successful presence in the country.

The program concluded with a networking reception, allowing participants to connect directly with industry leaders, potential partners, and fellow innovators. This session was an excellent opportunity to gain firsthand insights from key players in the Boston-Cambridge life science ecosystem and to make connections that could support their expansion efforts.

The Boston-Cambridge region, known for its world-class academic institutions, vibrant investor network, renowned healthcare facilities, and top-tier talent, provides an ideal environment for companies aiming to innovate and grow. For international companies seeking to enter the U.S. market, the Soft-Landing program offered an invaluable guide to leveraging these local resources for success.